Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00404690
Other study ID # 06 09 141
Secondary ID
Status Terminated
Phase N/A
First received November 27, 2006
Last updated January 27, 2016
Start date October 2006
Est. completion date October 2008

Study information

Verified date January 2016
Source Children's Mercy Hospital Kansas City
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The hypothesis is that there is no difference between bedside silo placement and operative closure in return of bowel function, ventilator dependence, or length of stay.

The primary outcome variable between the two techniques will be determined from this study that can then be used to develop a definitive study. The likely variables will be length of time to meet discharge criteria, length of hospitalization, time to full feedings, time on mechanical ventilation and total hospital charges.


Description:

A strategy of blocked randomization will be utilized. The randomization will be blocked in groups of 4. Randomization sequence will be kept by the principal investigator. After permission is obtained, the next assignment will be obtained. This method assures that the physician obtaining permission will be blind to the treatment group.

The treatment groups will consist of the same medical management, feeding regimen and discharge criteria.

The interventions will be either bedside silo or operative attempt at closure. During attempt at primary closure, the abdomen will be closed completely if the staff anesthesiologist and surgeon agree the belly is not too tight based on ventilatory parameters, vital signs and appearance. If either the surgeon or anesthesiologist should feel the closed abdomen is too tight, a ringed silo will be placed in the operating room, the same silo used in the bedside treatment arm, and the child will continue in the study. When a silo is placed either in the operating room due to inability to close the abdomen or at the bedside, they will be managed the same way. The skin will be dressed in the standard fashion (betadine jelly, xeroform and kerlix). The dressing allows visualization of the bowel. No reductions will be done the day of placement. After one night of observation a tie will be gently placed to apply downward pressure on the bowel. This pressure will not be allowed to increase the peak ventilator pressure by more than 2 cm H2O. One tie will be placed each subsequent day until the tie is within 2 cm of the skin at which point the patient will be scheduled for operative closure the day following the placement of the tie.

The medical management is controlled for resuscitation, sedation, ventilation and feeding between groups.


Recruitment information / eligibility

Status Terminated
Enrollment 20
Est. completion date October 2008
Est. primary completion date April 2008
Accepts healthy volunteers No
Gender Both
Age group N/A to 1 Day
Eligibility Inclusion Criteria:

- Patients with gastroschisis

Exclusion Criteria:

- Born prior to 34 weeks estimated gestational age

- Another congenital anomaly influencing the respiratory status, gastrointestinal status, or the length of hospitalization and recovery.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Bedside Silo
silo placed at bedside on admission
Operative attempt at closure
go the operating room to attempt closure

Locations

Country Name City State
United States The Children's Mercy Hospital Kansas City Missouri

Sponsors (1)

Lead Sponsor Collaborator
Children's Mercy Hospital Kansas City

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary this is a pilot study therefore there is no primary outcome variable 1 year
Secondary Time to full feeds, time of ventilation, hospital charges, total time in the operating room, number of operations, fluid resuscitation, total transfusion volume, fluid re 1 year
See also
  Status Clinical Trial Phase
Completed NCT00539292 - Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis Phase 2
Recruiting NCT03724214 - Multi-Centre Gastroschisis Interventional Study Across Sub-Saharan Africa N/A
Recruiting NCT01469208 - Music Therapy: An Adjunct To Gastroschisis Infants' Care N/A
Recruiting NCT05704257 - Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial N/A
Completed NCT03533439 - Regional Blood Saturation Levels in Gastroschisis
Active, not recruiting NCT03393832 - Oral Care in Infants With Gastroschisis
Completed NCT03666767 - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Terminated NCT03355326 - Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis Phase 4
Completed NCT03185637 - Children's Surgery in Sub-Saharan Africa N/A
Completed NCT02575846 - Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair N/A
Terminated NCT01094587 - Sutureless vs Sutured Gastroschisis Closure N/A
Active, not recruiting NCT00127946 - Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses Phase 3
Withdrawn NCT04186039 - Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations N/A
Completed NCT03960320 - Health Related Quality of Life of Patients With Abdominal Wall Defects
Terminated NCT02098915 - Metoclopramide Pilot Trial Phase 3
Completed NCT01316510 - Probiotics in Infants With Gastroschisis N/A
Completed NCT04020939 - The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. N/A
Recruiting NCT06072976 - The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies N/A
Recruiting NCT05293353 - Neokare Safety and Tolerability Assessment in Neonates With GI Problems
Completed NCT02370251 - Compassionate Use of Omegaven in Children Phase 2/Phase 3